FOSTER JAMES C sold $10.1M of CRL
FOSTER JAMES C sold 33,561 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $300.00 ($10.07M total) on 2026-08-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider sentiment, which traders may use to adjust short‑term positions.
Market read
Insider sell of $10M by a director is a modestly material event for CRL, offering a low‑to‑moderate trading signal.
What to watch
Potential upcoming earnings or product news that could offset the sell pressure.
Background
Form 4 filings disclose insider transactions and are primary sources of new corporate information.
Ticker impact
Director Foster James C sold 33,561 shares for $10.07M via a 10b5‑1 plan on 2026‑08‑25.
Potential modest downside pressure in the next trading session.
A $10M sale by a director is material for a mid‑cap biotech, but not large enough to trigger a major move.
Market effects
May raise concerns for the biotech services sector if other insiders follow suit.
Limited to US markets where CRL trades.
Low global relevance.
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals.
Key entities
- CompanyCharles River Laboratories International, Inc.
Provider of laboratory services and products to the pharmaceutical and biotech industries.
- IndividualFoster James C.
Director of Charles River Laboratories who executed the sale.
